With 5.1% CAGR, Mycoplasma Testing Market Size to Surpass USD 1,251.6 Million by 2030
Zion Market Research has published a new report titled “Mycoplasma Testing Market by Product (Instruments, Services and Kits & Reagent); by Technique (Enzymatic Methods, Microbial Culture Techniques, DNA Staining, Indirect Assay, Direct Assay, ELISA and PCR); by Application (End of Production Cells Testing, Virus Testing, Cell Line Testing and Other Applications); by End User (Research Institutes, Pharmaceutical And Biotechnology Companies, Cell Banks, Contract Research Organizations (CROs), and Others): Global Industry Perspective, Comprehensive Analysis and Forecast.
According to the global Mycoplasma Testing Market size is projected to reach USD 1,251.6 million in 2030, at a CAGR of 5.1% during the forecast period, 2023–2030
Mycoplasmas are smallest and simplest prokaryotic organisms found in humans, soil, plants, animals, insects and sewage. Mycoplasmas are able to grow in cell-free culture medium. Mycoplasmas are commonly called crabgrass of cell cultures as their infections are difficult to diagnose and detect. Mycoplasma infections are persistent and difficult to cure. Cell cultures contamination with mycoplasmas is severe concern for biotechnological industries and research laboratories using cell cultures. Most common origin of mycoplasma in cell cultures is culture medium, particularly serum. Thus mycoplasma testing is one of crucial step in cell culture.
The global mycoplasma testing market has seen tremendous demand over last few years and is expected to witness high growth in the coming years due to robust growth witnessed by biopharmaceutical and pharmaceutical industry across the globe. Additionally, demand for mycoplasma testing products is supported by rising investments in life science research, growing need to avoid cell culture contamination for meeting regulatory compliance and increasing R&D expenditure. Market growth for mycoplasma testing may be restrained due to presence of well-established market players. Also, time consuming approval procedures, stringent regulatory requirements, high degree of consolidation and lack of skilled professionals are factors that may act as restraining factors for the market growth. Increasing demand and use of mycoplasma testing outsourcing services is expected to act as growth opportunity for market players in mycoplasma testing. Global mycoplasma testing market is segmented based on product, technique, application, end user and region. Based on product, market is split into services, instruments and kits & reagents. Continuous and frequent use of kits and reagents has resulted in strong commercial sales and thus Kits and reagents segment accounted for largest market share in 2018. Kits and reagents segment is sub segmented into stains, standards & controls, elimination kits & reagent, PCR assay, nucleic acid detection, and other kits & reagents. Services segment is projected to register highest growth in the coming years.
Based on technique, global mycoplasma testing market is segmented into microbial culture techniques, enzymatic methods, DNA staining, direct assay, PCR, indirect assay, and ELISA. Among technique segment, PCR held largest market share in 2018. PCR technique offers accuracy, speed, and flexibility in life science research and thus is widely used technique accounting for largest market share.
The application segment is categorized into cell line testing, end of production cells testing, virus testing, and other applications. Cell line testing was the largest application segment for mycoplasma testing market in 2018. This large share is attributed to surge in drug development activities by key biopharmaceutical and pharmaceutical companies. Stringent regulatory requirements have resulted in growth in adoption of mycoplasma testing which is expected to boost market growth over the forecast period.
Cell banks, contract research organizations (CROs), pharmaceutical and biotechnology companies, research institutes, and others are end users of the market. Pharmaceutical and biotechnology companies were the largest end users of the global mycoplasma testing market in 2018. Increasing cell line research for biomolecule development and growth in R&D investments are factors attributing to the large market share.
At regional level, North America was leading market for global mycoplasma testing in 2018. Presence of major biopharmaceutical manufacturers, Developed biopharmaceutical industry, increasing investments and developed R&D infrastructure are factors driving the market growth in this region. Europe was second largest regional market in terms of revenue share. Increasing demand for biopharmaceutical research, presence of developed infrastructure, government initiatives to support R&D are major factors that support market growth in this region. Latin America is projected to exhibit noticeable growth over the forecast period. Asia Pacific region will witness rapid growth for mycoplasma testing market in the years to come. Surge in biopharmaceutical and pharmaceutical research, growing focus of contract research organizations on capturing growth opportunities in emerging Asia Pacific nations and offering outsourcing services to pharmaceutical manufacturers, government initiatives to support biopharmaceutical research are factors promoting mycoplasma testing market growth in Asia Pacific. Middle East and Africa may witness sluggish growth due to lack of developed infrastructure and funds.
Major players included in the report are -
- PromoCell GmbH
- Agilent Technologies
- SGS S.A.
- Eurofins ScientificMerck KGaA
- Roche Diagnostics
- Charles River Laboratories International
- Lonza Group Ltd.
- American Type Culture Collection
- Thermo Fisher Scientific Inc.
The report segment of global mycoplasma testing market as follows:
Global Mycoplasma Testing Market: By Product
- Kits & ReagentPCR AssayNucleic Acid DetectionElimination Kits & ReagentStainsStandards & ControlsOther Kits & Reagent
- Services
- Instruments
Global Mycoplasma Testing Market: By Technique
- PCR
- ELISA
- Direct Assay
- Indirect Assay
- DNA Staining
- Microbial Culture Techniques
- Enzymatic Methods
Global Mycoplasma Testing Market: By Application
- Cell Line Testing
- Virus Testing
- End of Production Cells Testing
- Other Applications
Global Mycoplasma Testing Market: By End User
- Research Institutes
- Pharmaceutical And Biotechnology Companies
- Cell Banks
- Contract Research Organizations (CROs)
- Other End Users
Global Mycoplasma Testing Market: By Region
- North AmericaU.S.
- EuropeUKFranceGermany
- Asia PacificChinaJapanIndia
- Latin AmericaBrazil
- Middle East and Africa
About Us:
Zion Market Research is an obligated company. We create futuristic, cutting-edge, informative reports ranging from industry reports, the company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us — after all — if you do well, a little of the light shines on us.
Contact Us:
Zion Market Research 244 Fifth Avenue, Suite N202 New York, 10001, United States Tel: +49–322 210 92714 USA/Canada Toll-Free №1–855–465–4651 Email: sales@zionmarketresearch.com Website: https://www.zionmarketresearch.com